RESUMO
Neisserial adhesin A (NadA) is a meningococcal surface protein included as recombinant antigen in 4CMenB, a protein-based vaccine able to induce protective immune responses against Neisseria meningitidis serogroup B (MenB). Although NadA is involved in the adhesion/invasion of epithelial cells and human myeloid cells, its function in meningococcal physiology is still poorly understood. To clarify the role played by NadA in the host-pathogen interaction, we sought to identify its cellular receptors. We screened a protein microarray encompassing 2,846 human and 297 mouse surface/secreted recombinant proteins using recombinant NadA as probe. Efficient NadA binding was revealed on the paired sialic acid-binding immunoglobulin-type lectins receptors 5 and 14 (Siglec-5 and Siglec-14), but not on Siglec-9 therein used as control. The interaction was confirmed by biochemical tools with the determination of the KD value in the order of nanomolar and the identification of the NadA binding site by hydrogen-deuterium exchange coupled to mass spectrometry. The N-terminal domain of the Siglec-5 that recognizes the sialic acid was identified as the NadA binding domain. Intriguingly, exogenously added recombinant soluble Siglecs, including Siglec-9, were found to decorate N. meningitidis surface in a NadA-dependent manner. However, Siglec-5 and Siglec-14 transiently expressed in CHO-K1 cells endorsed NadA binding and increased N. meningitidis adhesion/invasion while Siglec-9 did not. Taken together, Siglec-5 and Siglec-14 satisfy all features of NadA receptors suggesting a possible role of NadA in the acute meningococcal infection.IMPORTANCEBacteria have developed several strategies for cell colonization and immune evasion. Knowledge of the host and pathogen factors involved in these mechanisms is crucial to build efficacious countermoves. Neisserial adhesin A (NadA) is a meningococcal surface protein included in the anti-meningococcus B vaccine 4CMenB, which mediates adhesion to and invasion of epithelial cells. Although NadA has been shown to bind to other cell types, like myeloid and endothelial cells, it still remains orphan of a defined host receptor. We have identified two strong NadA interactors, Siglec-5 and Siglec-14, which are mainly expressed on myeloid cells. This showcases that NadA is an additional and key player among the Neisseria meningitidis factors targeting immune cells. We thus provide novel insights on the strategies exploited by N. meningitidis during the infection process, which can progress to a severe illness and death.
Assuntos
Adesinas Bacterianas , Antígenos CD , Antígenos de Diferenciação Mielomonocítica , Aderência Bacteriana , Interações Hospedeiro-Patógeno , Lectinas , Humanos , Adesinas Bacterianas/metabolismo , Adesinas Bacterianas/genética , Antígenos CD/metabolismo , Antígenos CD/genética , Lectinas/metabolismo , Lectinas/genética , Lectinas/imunologia , Animais , Antígenos de Diferenciação Mielomonocítica/metabolismo , Antígenos de Diferenciação Mielomonocítica/genética , Ligação Proteica , Camundongos , Células CHO , Cricetulus , Neisseria meningitidis/genética , Neisseria meningitidis/metabolismo , Neisseria meningitidis/imunologia , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/genética , Lectinas Semelhantes a Imunoglobulina de Ligação ao Ácido Siálico/metabolismo , Lectinas Semelhantes a Imunoglobulina de Ligação ao Ácido Siálico/genética , Células Epiteliais/microbiologia , Células Epiteliais/metabolismo , Células Epiteliais/imunologia , Infecções Meningocócicas/microbiologia , Infecções Meningocócicas/imunologia , Receptores de Superfície Celular/metabolismo , Receptores de Superfície Celular/genética , Neisseria meningitidis Sorogrupo B/genética , Neisseria meningitidis Sorogrupo B/imunologia , Neisseria meningitidis Sorogrupo B/metabolismoRESUMO
Se describen los casos de meningoencefalitis bacterianas exponiendo el análisis histórico de algunas variables y a continuación la información desde la Semana epidemiológica (SE) 1 a la 25 del año 2017 que provienen de la notificación por canales oficiales: SNVS (módulos C2/SIVILA) y SIC (Sistema de Información epidemiológica de CABA). El análisis de las infecciones invasivas no meníngeas será realizado en próximas actualizaciones. Los casos fueron notificados a través de estos sistemas por los efectores públicos y privados de la Ciudad. El análisis de los mismos se realizó de manera individual a fin de evitar duplicaciones, excluyendo los casos descartados e integrando la información en una base unificada. Se incluyeron como residentes de CABA a todos aquellos que se domicilian en la Ciudad y aquellos casos atendidos en efectores de la CABA cuyo domicilio es desconocido al momento del análisis. La construcción de las tasas, se realizó en base a las proyecciones poblacionales aportadas por la Dirección de Estadística y Censos (DGEyC) de la Ciudad Autónoma de Buenos Aires. (AU)
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Infecções Bacterianas/classificação , Infecções Bacterianas/imunologia , Infecções Bacterianas/transmissão , Infecções Bacterianas/epidemiologia , Vigilância Sanitária/estatística & dados numéricos , Notificação de Doenças , Infecções Meningocócicas/diagnóstico , Infecções Meningocócicas/imunologia , Infecções Meningocócicas/epidemiologia , Meningoencefalite/diagnóstico , Meningoencefalite/etiologia , Meningoencefalite/imunologia , Meningoencefalite/transmissão , Meningoencefalite/epidemiologiaRESUMO
Meningococcus serogroup B (MenB), clonal complex 32 (cc 32), was the Brazilian epidemic strain of meningococcal disease (MD) in the 1990’s. Currently, meningococcus serogroup C (MenC), cc 103, is responsible for most of the cases of the disease in Brazil. The aim of this study was to investigate the seroprevalence of bactericidal antibody (SBA) against representative epidemic strains of MenC, (N753/00 strain, C:23:P1.22,14-6, cc103) and MenB, (Cu385/83 strain, B:4,7:P1.15,19, cc32) in students and employees of a university hospital in the State of Rio Grande do Sul (RS, Brazil). A second MenC strain (N79/96, C:2b:P1.5-2,10, cc 8) was used as a prototype strain of Rio de Janeiro’s outbreak that occurred in the 1990’s. Our previous study showed a 9% rate of asymptomatic carriers in these same individuals. A second goal was to compare the SBA prevalence in meningococcal carriers and non-carriers. Fifty-nine percent of the studied population showed protective levels of SBA titers (log2≥2) against at least one of the three strains. About 40% of the individuals had protective levels of SBA against N753/00 and Cu385/83 strains. Nonetheless, only 22% of the individuals showed protective levels against N79/96 strain. Significantly higher antibody levels were seen in carriers compared to non-carriers (P≤0.009). This study showed that, similar to other States in Brazil, a MenC (23:P1.22,14-6, cc103) strain with epidemic potential is circulating in this hospital. Close control by the Epidemiological Surveillance Agency of RS of the number of cases of MD caused by MenC strains in the State is recommended to prevent a new disease outbreak.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Adulto Jovem , Anticorpos Antibacterianos/sangue , Neisseria meningitidis Sorogrupo B/imunologia , Neisseria meningitidis Sorogrupo C/imunologia , Brasil , Hospitais Universitários , Immunoblotting/métodos , Infecções Meningocócicas/imunologia , Neisseria meningitidis Sorogrupo B/isolamento & purificação , Neisseria meningitidis Sorogrupo C/isolamento & purificação , Estudos Soroepidemiológicos , Sorogrupo , Ensaios de Anticorpos Bactericidas Séricos , Estatísticas não ParamétricasRESUMO
Serogroup B Neisseria meningitidis (MenB) is a major cause of invasive disease in early childhood worldwide. The only MenB vaccine available in Brazil was produced in Cuba and has shown unsatisfactory efficacy when used to immunize millions of children in Brazil. In the present study, we compared the specific functional antibody responses evoked by the Cuban MenB vaccine with a standard vaccine against diphtheria (DTP: diphtheria, tetanus, pertussis) after primary immunization and boosting of mice. The peak of bactericidal and opsonic antibody titers to MenB and of neutralizing antibodies to diphtheria toxoid (DT) was reached after triple immunization with the MenB vaccine or DTP vaccine, respectively. However, 4 months after immunization, protective DT antibody levels were present in all DTP-vaccinated mice but in only 20% of the mice immunized against MenB. After 6 months of primary immunization, about 70% of animals still had protective neutralizing DT antibodies, but none had significant bactericidal antibodies to MenB. The booster doses of DTP or MenB vaccines produced a significant antibody recall response, suggesting that both vaccines were able to generate and maintain memory B cells during the period studied (6 months post-triple immunization). Therefore, due to the short duration of serological memory induced by the MenB vaccine (VA-MENGOC-BC® vaccine), its use should be restricted to outbreaks of meningococcal disease.
Assuntos
Animais , Feminino , Camundongos , Anticorpos Antibacterianos/imunologia , Toxoide Diftérico/imunologia , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Infecções Meningocócicas/imunologia , Neisseria meningitidis/imunologia , Formação de Anticorpos , Antígenos de Bactérias/imunologia , Memória Imunológica , Infecções Meningocócicas/prevenção & controle , Vacinas Meningocócicas/imunologia , Fatores de TempoRESUMO
Neisseria meningitidis sao diplococos Gram negativos responsaveis por casos de doencas meningococica em todo o mundo. O potencial epidemico de N. meningitidis sorogrupos B e C e claramente mais uma funcao de seus antigenos de sorotipo que de seu polissacaride capsular. Ate recentemente soros hiperimune foram usados para detectar antigenos de sorotipo em bacterias. O advento de anticorpos monoclonais ofereceu a oportunidade de eliminar muitas das reacoes cruzadas e tem melhorado a acuracidade e reprodutibilidade da sorotipagem de meningococo. Nos produzimos um anticorpo monoclonal contra proteina de membrana externa do sorotipo 17 que ate entao tem sido detectado atraves do uso de soro policlonal. A prevalencia deste epitopo de sorotipo e baixa nas cepas brasileiras. Usando-se este anticorpo monoclonal em cepas brasileiras, nao pudemos diminuir a porcetagem de cepas sorogrupo C nao tipaveis, entretanto, houve uma diminuicao de 13 por cento em cepas sorogrupo B nao tipaveis e 25 por cento em cepas de outros sorogrupos.